[Relapses and indirect fluorescent antibody level in vivax malaria patients after chloroquine and chloroquine-primaquine treatment].
D000906:Antibodies / Q000032:analysis*; D002738:Chloroquine / Q000627:therapeutic use*; D005455:Fluorescent Antibody Technique; D006801:Humans; D008288:Malaria / Q000188:drug therapy* / Q000276:immunology; D010966:Plasmodium vivax / Q000276:immunology; D011319:Primaquine / Q000008:administration & dosage*; D012008:Recurrence
D000906:Antibodies; D002738:Chloroquine; D011319:Primaquine